Lemon Healthcare KRX:365660KOSDAQ
레몬헬스케어 · Korean news coverage and regulatory filings, organized.
Articles, 24h0
Articles, 7 days1
DART filings, 7 days0
Articles tracked4since Sep 11
In Q2 2026, Lemon Healthcare reported revenue of ₩2.9bn, down 35.3% year on year, and an operating loss of ₩2.1bn. Lemon Healthcare (레몬헬스케어) appeared in 1 Korean news article and 0 DART filings over the past seven days. Coverage peaked on Oct 20 with 1 article. The most common catalyst was contracts & orders (1). It was most often mentioned alongside G2gbio and OliX Pharmaceuticals.
Filing signals Swung to loss Screener
Lemon Healthcare quarterly results separate, KRW
| Quarter | Revenue | YoY | Operating profit | Net income |
|---|---|---|---|---|
| Q2 2026 | ₩2.9bn | -35.3% | −₩2.1bn margin −72.6% | −₩2.1bn |
| Q2 2025 | ₩4.5bn | – | ₩368m margin 8.1% | ₩588m |
Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases. Margin is operating profit divided by revenue — see operating margin.
Lemon Healthcare top stories 2 weeks, by number of outlets
- 1
- 2
- 3
- 4